NCT00602641 2026-03-03
Melphalan, Prednisone, and Thalidomide or Lenalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
National Cancer Institute (NCI)
Phase 3 Active not recruiting
National Cancer Institute (NCI)
Medical University of Vienna
Institute of Hematology & Blood Diseases Hospital, China
University of Arkansas
Shanghai Zhongshan Hospital